QNTM · NASDAQ
Quantum Biopharma (QNTM) Stock Price & Fundamentals
$462.37+1.38%+$6.28End-of-day price as of Oct 9, 2026
Sample prices
Prices on this page are generated sample data for development, not real market data, so market cap, P/E and dividend yield are illustrative too.
Quantum Biopharma (QNTM) closed at $462.37 on Oct 9, 2026, up 1.38% from the previous close of $456.09.
Share price, past year
1Y +8.35%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $462.37 |
| Sep 30, 2026 | $474.08 |
| Aug 31, 2026 | $459.14 |
| Jul 31, 2026 | $469.82 |
| Jun 30, 2026 | $429.02 |
| May 29, 2026 | $446.07 |
| Apr 30, 2026 | $444.82 |
| Mar 31, 2026 | $459.26 |
| Feb 27, 2026 | $448.08 |
| Jan 30, 2026 | $465.59 |
| Dec 31, 2025 | $445.39 |
| Nov 28, 2025 | $416.87 |
| Oct 31, 2025 | $423.35 |
Key statistics
- 52-week range
- $410.56 – $488.74
Financials
Quantum Biopharma reports to the SEC in international accounting standards (IFRS), which Laurel doesn't show yet.
Company profile
- Name
- Quantum Biopharma Ltd.
- Ticker
- QNTM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 1 Adelaide Street East, Suite 801, Toronto, M5C 2V9
- Incorporated in
- A6
- Fiscal year ends
- December
- SEC CIK
- 0001771885
Frequently asked questions
What is Quantum Biopharma's stock price?
Quantum Biopharma (QNTM) closed at $462.37 on Oct 9, 2026, up 1.38% from the previous close of $456.09.
Sources and methodology
Fundamentals come from Quantum Biopharma Ltd.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures